$4.26
0.020.47%
Últ. Act.: Nov 6, 7:52 PM
The average analyst price target for Cingulate is $21.25, 400.0% above the current price. Of 6 analysts, 5 rate it Buy and 1 Hold. Targets range from $9 to $44. The latest change came on Aug 24, 2026, when Roth Capital lowered its price target on Cingulate from $10 to $9 and kept a Buy rating.
Price Target Range — 8 Quarters
Analyst Consensus — 6 Analysts
Rating Trend — Last 9 Months